Register entry

Aveva Drug Delivery Systems Inc.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
23
Labeller names
2
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Aveva Drug Delivery Systems Inc.3250 Commerce Parkway, Miramar, Florida (FL) 33025, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging1000307689783982093
Catalogue

Drug listings by form and route

23

23 active NDC listings: 17 human prescription drug, 6 human otc drug. By marketing category: ANDA 23.

Dosage formNDCs
patch, extended release13
patch6
film4
RouteNDCs
transdermal19
buccal4
sublingual4
Labeller name on the listingNDCs
aveva drug delivery systems inc.20
aveva drug delivery systems, inc.3
Catalogue

Marketed products

23
BrandGeneric nameForm / routeNDC
BuprenorphineBuprenorphinepatch, extended release, transdermal3215-1521ANDA
BuprenorphineBuprenorphinepatch, extended release, transdermal3215-1522ANDA
BuprenorphineBuprenorphinepatch, extended release, transdermal3215-1523ANDA
BuprenorphineBuprenorphinepatch, extended release, transdermal3215-1524ANDA
BuprenorphineBuprenorphinepatch, extended release, transdermal3215-1525ANDA
Buprenorphine and Naloxonebuprenorphine and naloxonefilm, buccal, sublingual3215-6521ANDA
Buprenorphine and Naloxonebuprenorphine and naloxonefilm, buccal, sublingual3215-6522ANDA
Buprenorphine and Naloxonebuprenorphine and naloxonefilm, buccal, sublingual3215-6523ANDA
Buprenorphine and Naloxonebuprenorphine and naloxonefilm, buccal, sublingual3215-6524ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7701ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7702ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7703ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7704ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7705ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7706ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7707ANDA
FENTANYLFENTANYLpatch, extended release, transdermal3215-7708ANDA
Nicotine Transdermal SystemNicotine Transdermal Systempatch, transdermal3215-0120ANDA
Nicotine Transdermal SystemNicotine Transdermal Systempatch, transdermal3215-0121ANDA
Nicotine Transdermal SystemNicotine Transdermal Systempatch, transdermal3215-0122ANDA
Nicotine Transdermal SystemNicotine Transdermal Systempatch, transdermal3215-1201ANDA
Nicotine Transdermal SystemNicotine Transdermal Systempatch, transdermal3215-1202ANDA
Nicotine Transdermal SystemNicotine Transdermal Systempatch, transdermal3215-1203ANDA
Compare

Comparable companies in United States

Enquiry

Common questions

Is Aveva Drug Delivery Systems Inc. FDA approved?
Aveva Drug Delivery Systems Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Aveva Drug Delivery Systems Inc.'s drugs manufactured?
The FDA register lists Miramar, FL. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Aveva Drug Delivery Systems Inc. make?
23 products are listed under Aveva Drug Delivery Systems Inc. in the openFDA NDC Directory, most often as patch, extended release; patch; film. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.